Alvotech (ALVO) Cash from Investing Activities (2022 - 2025)
Alvotech (ALVO) reported Cash from Investing Activities of -$15.8 million for Q4 2025, up 16.44% on a YoY basis from -$13.5 million in Q4 2024, and up 60.04% quarter-over-quarter from -$39.5 million in Q3 2025.
Alvotech (ALVO) Cash from Investing Activities (2022 - 2025) Analysis & Trends
Alvotech has reported Cash from Investing Activities for 4 years, with the latest figure at -$15.8 million in Q4 2025.
- For the quarter ending Q4 2025, Cash from Investing Activities rose 16.44% year-over-year to -$15.8 million; the trailing twelve-month figure through Dec 2025 stood at -$104.2 million (down 1459.17% YoY), and the FY2025 full-year result was -$104.2 million, down 452.34% from the prior year.
- Cash from Investing Activities for Q4 2025 stood at -$15.8 million, up from -$39.5 million in the prior quarter.
- The five-year high for Cash from Investing Activities was $22.8 million in Q3 2024, with the low at -$63.5 million in Q4 2022.
- Historically, Cash from Investing Activities has averaged -$20.5 million across 4 years, with a median of -$17.3 million in 2024.
- Annual changes were most pronounced in 2024 — Cash from Investing Activities jumped 74.92% — and 2025, when it tumbled 486.06%.
- Alvotech's Cash from Investing Activities stood at -$63.5 million in 2022, then advanced by 27.07% to -$46.3 million in 2023, then soared by 59.28% to -$18.9 million in 2024, then gained by 16.44% to -$15.8 million in 2025.
- The last three Cash from Investing Activities figures came in at -$15.8 million (Q4 2025), -$39.5 million (Q3 2025), and -$28.6 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 229.00 Mn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | -87.00 Mn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 743.70 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | -506.20 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | -60.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | -2.08 Bn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 25.99 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | -15.45 Mn |
| 10 | Alvotech | 12.20 Mn | -160.16 Mn | -22.39 Mn | -15.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -15.77 Mn |
| Dec 31, 2025 | -15.77 Mn |
| Sep 30, 2025 | -39.45 Mn |
| Sep 30, 2025 | -39.45 Mn |
| Jun 30, 2025 | -28.60 Mn |
| Jun 30, 2025 | -28.60 Mn |
| Mar 31, 2025 | -20.40 Mn |
| Mar 31, 2025 | -20.40 Mn |
| Dec 31, 2024 | -18.87 Mn |
| Dec 31, 2024 | -18.87 Mn |
| Sep 30, 2024 | 22.75 Mn |
| Sep 30, 2024 | 22.75 Mn |
| Jun 30, 2024 | -7.09 Mn |
| Jun 30, 2024 | -7.09 Mn |
| Mar 31, 2024 | -3.48 Mn |
| Mar 31, 2024 | -3.48 Mn |
| Dec 31, 2023 | -46.34 Mn |
| Dec 31, 2023 | -46.34 Mn |
| Jun 30, 2023 | -11.35 Mn |
| Jun 30, 2023 | -11.35 Mn |